利莫那班部分减轻年轻与老年肌少症雄性小鼠制动后的骨骼肌丢失
Muscle tissue is important for locomotion and metabolic health. Muscle disuse (eg, postoperative) occurs more often in older adults and results in rapid muscle wasting.…
要点
- 利莫那班减轻制动后腓肠肌质量丢失,年轻和老年小鼠均受益。
- 利莫那班未改变制动诱导的合成与分解标志物表达变化。
- 利莫那班意外放大制动诱导的肌肉蛋白质合成下降,年轻鼠更明显。
核心结论
- 利莫那班部分减轻年轻和老年肌少症雄性小鼠制动诱导的腓肠肌质量丢失。
- 利莫那班意外放大制动诱导的肌肉蛋白质合成下降,且年轻鼠放大程度大于老年鼠。
研究设计与样本
- 研究对年轻和老年雄性C57BL/6小鼠单后肢制动5天,同时每日给予利莫那班10 mg/kg或溶媒,之后处死收集肌肉。
- 通过蛋白质印迹分析腓肠肌内源性大麻素、合成及分解标志物。
主要发现
- 制动增加合成调节因子p-S6rp、p-4E-BP1及分解标志物LC3b-II/I、MAFbx表达,利莫那班未改变这些变化。
- 制动降低NAPE-PLD表达而增加FAAH表达。
临床怎么用
- 目前不能将利莫那班用于老年制动性肌萎缩的临床防治,其肌肉保护机制及对蛋白质合成的负面影响需进一步研究。
局限性
- 研究为小鼠实验,制动模型仅5天,结果不能直接外推至老年人群。
- 利莫那班肌肉保护效应与蛋白质合成下降的矛盾机制未阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Muscle tissue is important for locomotion and metabolic health. Muscle disuse (eg, postoperative) occurs more often in older adults and results in rapid muscle wasting. Currently, there is no effective treatment to combat immobilization-induced atrophy, which is why novel therapeutic strategies are needed. Antagonism of cannabinoid receptor 1 (CB1) can stimulate muscle protein synthesis, thereby protecting against glucocorticosteroid-induced atrophy. However, its therapeutic potential against (age-related) immobilization-induced atrophy remains unknown. Therefore, we investigated the effect of CB1 antagonism on muscle responses following immobilization in young and old, sarcopenic male mice. One hind limb of young and old male C57BL/6 mice was immobilized for 5 days, during which they were treated with the CB1 antagonist Rimonabant (10 mg/kg per day) or vehicle. Hereafter, mice were euthanized and muscles were collected. Endocannabinoid, anabolic, and catabolic markers were analyzed in the gastrocnemius muscle via western blotting. Rimonabant attenuated immobilization-induced gastrocnemius muscle mass loss in both ages (-7.9% vs vehicle: -11.2%; P = .0027). Immobilization increased expression of the anabolic regulators (p-S6rp, p-4E-BP1), and of the catabolic markers (LC3b-II/I, MAFbx), which remained unaffected by Rimonabant treatment. Surprisingly, Rimonabant amplified the immobilization-induced decrease in muscle protein synthesis (-45.8% vs vehicle: -27%; P = .0180) to a larger extent in young vs old mice (P = .0005). Immobilization decreased the expression of the enzyme NAPE-PLD, responsible for the synthesis of the endocannabinoid anandamide, whereas its degrading enzyme FAAH was higher expressed. More research is needed to unravel the mechanisms underlying the muscle-sparing effect of Rimonabant and anandamide's role in muscle degeneration.
引用
- Dalle S, Vanderbeke K, Schouten M, et al. Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice. J Gerontol A Biol Sci Med Sci. 2025. PMID: 40875529. doi:10.1093/gerona/glaf189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。